Observational studyBMC nephrology2026
Risk factors and outcomes of culture-negative peritonitis in peritoneal dialysis: 10 years' insight from a large center in northern China.
Observational study in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PNI, CONUT, and GNRI for predicting treatment failure in peritoneal dialysis-associated peritonitis: a two-center retrospective study.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPeritoneal dialysis-associated peritonitis is the primary cause of technical failure and infection-related mortality in PD patients. Culture-negative peritonitis poses unique management challenges. The reported incidence of culture-negative peritonitis varies substantially across regions and centers, likely reflecting differences in patient characteristics, microbiological practices, and treatment protocols. In this study, we aimed to investigate the risk factors, treatment strategies, and clinical outcomes of culture-negative peritonitis in a large peritoneal dialysis center in northern China.
methodsIn this single-center retrospective cohort study, we included consecutive peritonitis episodes from January 2013 to December 2023. We assessed patient demographics, medical history, peritonitis presentation, antibiotic use, and treatment pathways. The primary outcomes were culture-negativity and outcomes of medical cure. Logistic regression was used to identify independent risk factors for culture negativity and failure to achieve a medical cure.
resultsThe overall incidence of peritonitis during the study period was 0.15 episodes per patient-year and the culture-negative peritonitis rate was 25.5%. Patients with culture-negative peritonitis were more likely to have a smoking history (P = 0.026) and to have used antibiotics before culture collection (47.6% vs. 9.2%, P < 0.0001). A higher proportion of culture-negative cases experienced a delay of over a day from hospital presentation to obtaining a culture (27.0% vs. 8.7%, P = 0.0009). Multivariate analysis revealed that only antibiotic use before culture independently predicted culture negativity (OR = 12.40, 95% CI = 3.80 to 40.20, P < 0.0001). Culture-negative peritonitis had a medical cure rate of 76.2%, similar to Gram-positive infections (76.2% vs. 67.3%, P = 0.229) and better than Gram-negative, polymicrobial, fungal, or tuberculosis-related peritonitis. In multivariate analysis, longer dialysis vintage, culture positivity, and higher post-peritonitis hsCRP levels were associated with a failure to achieve a medical cure.
conclusionCulture-negative peritonitis had favorable outcomes compared to Gram-negative and polymicrobial peritonitis. Increased patient awareness and an optimized treatment pathway can enhance a timely and standardized culture collection and reduce the culture-negative rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.